Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia

D Sánchez-Martínez, ML Baroni… - Blood, The Journal …, 2019 - ashpublications.org
Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) has a dismal outcome, and
no effective targeted immunotherapies for T-ALL exist. The extension of chimeric antigen …

[HTML][HTML] A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL

SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera… - Molecular Therapy, 2022 - cell.com
CD19-directed chimeric antigen receptor (CAR) T cells have yielded impressive response
rates in refractory/relapse B cell acute lymphoblastic leukemia (B-ALL); however, most …

Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS‐CoV‐2 pandemic

A Faura, S Rives, Á Lassaletta… - Pediatric blood & …, 2020 - Wiley Online Library
To the Editor: In December 2019, the SARS-CoV-2 outbreak started in China and rapidly
progressed into a pandemic. 1 Spain was one of the first countries in Europe reporting …

Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow …

A Pérez‐Martínez, C Ferreras, A Pascual… - American Journal of …, 2020 - Wiley Online Library
A total of 192 pediatric patients, median age 8.6 years, with high‐risk hematological
malignancies, underwent haploidentical stem cell transplantation (haplo‐HSCT) using post …

[HTML][HTML] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

M Forero-Castro, C Robledo, R Benito… - British journal of …, 2017 - nature.com
Background: In B-cell precursor acute lymphoblastic leukaemia (B-ALL), the identification of
additional genetic alterations associated with poor prognosis is still of importance. We …

[HTML][HTML] Genome-wide DNA copy number analysis of acute lymphoblastic leukemia identifies new genetic markers associated with clinical outcome

M Forero-Castro, C Robledo, R Benito, M Abaigar… - PLoS …, 2016 - journals.plos.org
Identifying additional genetic alterations associated with poor prognosis in acute
lymphoblastic leukemia (ALL) is still a challenge. Aims: To characterize the presence of …

[HTML][HTML] Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity

SR Zanetti, PA Romecin, M Vinyoles… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Although adoptive transfer of CD19-directed chimeric antigen receptor (CAR) T-
cells (CD19-CAR T-cells) achieves high rates of complete response in patients with B-cell …

[HTML][HTML] L-Ferritin: one gene, five diseases; from hereditary hyperferritinemia to hypoferritinemia—Report of new cases

B Cadenas, J Fita-Torró, M Bermúdez-Cortés… - Pharmaceuticals, 2019 - mdpi.com
Ferritin is a multimeric protein composed of light (L-ferritin) and heavy (H-ferritin) subunits
that binds and stores iron inside the cell. A variety of mutations have been reported in the L …

[HTML][HTML] Hereditary hyperferritinemia cataract syndrome: ferritin L gene and physiopathology behind the disease—report of new cases

F Celma Nos, G Hernández, X Ferrer-Cortès… - International Journal of …, 2021 - mdpi.com
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare disease characterized by
high serum ferritin levels, congenital bilateral cataracts, and the absence of tissue iron …

Genetic and phenotypic findings in 34 novel Spanish patients with DDX3X neurodevelopmental disorder

A Parra, P Pascual, M Cazalla, P Arias… - Clinical …, 2024 - Wiley Online Library
DDX3X is a multifunctional ATP‐dependent RNA helicase involved in several processes of
RNA metabolism and in other biological pathways such as cell cycle control, innate …